Moreover, cotreatment with NPA could regulate IR through restoring phosphorylation of IRS-1 and alleviating phosphorylation of JNK in liver tissue, suggesting its involvement in modulating IR by protein phosphorylation during NAFLD progression. The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatotic liver disease.